INTRODUCTION
Rheumatic manifestations are ten to fifteen times more common in patients with psoriasis than in the general population. Psoriasis patients even show a percentage greater than 40% of inflammatory joint manifestations.
1 Between 5% and 40% of the patients who suffer from psoriasis will develop psoriatic arthritis, but not every patient with psoriasis will present with psoriatic arthritis and not any joint manifestation is psoriatic arthritis. Rheumatoid arthritis, osteoarthritis and joint pain are common in the general population and in patients with psoriasis.
2 Nevertheless, it is recommended that specific enquiry about joint disease should be sought in all patients with psoriasis.
While the prevalence of arthritis in the general population is estimated at 2-3%, in patients with psoriasis it varies from 7 to 42%. 3 Moll and Wright concluded from a review of epidemiological studies and scientifically support the concept that psoriatic arthritis is a single entity, with clinical, serological and radiological characteristics, and provided the earliest diagnostic criteria for psoriatic arthritis. [4] [5] [6] Nowadays it is generally agreed that while psoriatic arthritis can be classified among spondyloarthropathies, a family of disorders sharing common features like inflammatory arthritis, axial involvement, enthesopathy, absence of rheumatoid factor and association with HLA. 5, 6 There is no general agreement in the literature regarding the prevalence of psoriatic arthritis. The estimate of prevalence has been difficult because of the paucity of widely accepted classification or diagnostic criteria and the difficulty of most experts in making a correct diagnosis.
5
There are still some difficulties for the diagnosis of psoriatic arthritis, so several classification criteria have been proposed. 7 The CASPAR criteria for classification are comparable to others but have shown better sensitivity, facilitating the recruitment of patients in studies of psoriatic arthritis.
8
The typical clinical features of psoriatic arthritis include distal joint involvement which occurs in more than half of patients, but its isolated occurrence is rare. Oligoarticular involvement is seen and about half of patients have the spondyloarthropathy form, which is usually less symptomatic when compared to ankylosing spondylitis. Half of the patients also have dactylitis and enthesitis. 4 More recently, three joint patterns were identified: oligoarticular (£ 4 affected joints) or polyarticular (≥ 5 joints affected) or peripheral pattern and axial pattern with or without associated peripheral arthritis.
9
Considering the lack of national data related to the diagnosis of psoriatic arthritis in patients with psoriasis, this study aims to describe the clinical, laboratorial and radiological features in 133 psoriatic patients with and without psoriatic arthritis from the outpatients´ clinic of dermatology at the Brasília University Hospital.
PATIENTS AND METHODS Sample
We carried out a cross-sectional study in 133 patients with psoriasis who visited the Outpatient´s Department of Dermatology at University Hospital of Brasilia, between November 2009 and December 2010. Convenience sampling was done and our sample represented 33% of all the patients already enrolled in the psoriasis outpatients´ clinic.
The study was approved by the local ethics committee according to Brazilian Standards for Research involving Human Subjects and the Helsink Declaration. We recruited consecutively and included patients diagnosed with psoriasis, according to clinical criteria by an experienced dermatologist and/or biopsy. All patients who agreed to participate in the study signed the informed consent form.
METHODS
Psoriasis's clinical evaluation was performed by a dermatologist. The study followed the routine of the dermatological service with filling of the specific form where the first skin symptoms, the year of diagnosis, the form of the disease, nail involvement, scalp involvement, smoking, alcohol consumption, diseases history, previous treatments and family history of psoriasis were recorded. The form was sent to the rheumatologist to collect information for the study.
All patients who agreed to participate in this study were evaluated by a rheumatologist on the same day by the protocol for evaluation of joint manifestations, which included the presence of pain / joint swelling, dactylitis, enthesitis, neck pain, back pain, previous diagnosis of psoriatic arthritis or other forms of arthritis, date of diagnosis and type of joint involvement.
The rheumatologist was the first author of this study and evaluated all patients according to the recommendations by GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and the OMERACT (Outcome Measures in Rheumatology Clinical Trials).
10 Thus the axial and peripheral skeletons were clinically evaluated.
11
The suspected cases of psoriatic arthritis were sent to laboratorial and radiological research. The diagnosis of psoriatic arthritis was made according to the CASPAR criteria.
12

Statistical Analysis
We conducted the Kolmogorov-Smirnov test to verify the normality of the sample and then used the X ² test, Fischer exact test, Student T and Mann-Whitney tests. Statistical analyses were undertaken by SPSS ® version 15.0 (SPSS Inc., Chicago, IL, USA). A p-value less than 0.05 was considered statistically significant (p <0.05).
RESULTS
Considering the prevalence of 25% of psoriatic arthritis in patients with psoriasis the power of the sample was 60%.
We evaluated 62 men and 71 women diagnosed with psoriasis. The average age of the sample was 47.5 (± 13.4) years, ranging between 17 and 82 years. Seven patients reported current alcohol use and 12 were smokers. Eighteen patients had a high blood pressure (13.5%) and 10 (7.5%) had a diagnosis of diabetes mellitus. Only five patients reported a family history of psoriasis and there was no information in this regard in 97 of the dermatological reports.
Chart 1 shows the sex distribution by type of psoriasis. There was no information on the classification form of psoriasis from 25 patients.
It is noteworthy that all five patients with the palmoplantar form were women and two with the erythrodermic form were male.
Thirty-nine patients (39%) had nail involvement, according to the dermatologist. However, in 50 (38%) patients, the dermatologist did not report whether there were nail changes.
Regarding the presence of scalp involvement, lesions were reported in 66 (49.6%) patients, but there was no information on injuries to the scalp in 49 (36.8%) patients.
As for the complaints of the musculoskeletal system, one hundred and one patients (80.5%) had joint pain, 91 (68.4%) reported back pain and 67 (50.4%) neck pain.
The presence of enthesitis was found in 17 (12.8%) patients and the diagnosis of dactylitis was made in 27 patients (20.3%) at the time of the assessment by the rheumatologist. Regarding the use of drugs by the patients, it was observed that 30 (22.6%) patients used anti-inflammatory drugs, 22 (16.5%) patients used disease-modifying drugs and the use of biological drugs was reported by 08 (6%) patients.
Previous diagnosis of psoriatic arthritis was reported by 30 (22.6%) patients with psoriasis. The disease was present in 35% of men and 25% of women. Seventeen patients not previously diagnosed were diagnosed using the CASPAR criteria. Therefore, the number of patients with psoriatic arthritis in the study sample was 47 patients, or 35% of the sample. However, in this study, for the purpose of analyzing the group with psoriatic arthritis, only patients classified by the CASPAR criteria, at the moment of the study, were considered.
Patients with psoriatic arthritis had an average age of 49 (± 13.2) years, the average age of the population without arthritis was 47 (± 14.4) years. No association was found between the groups with and without psoriatic arthritis and previous symptoms of joint, back and neck pain.
There was a great variability in terms of the time between the first skin symptoms and the diagnosis of psoriatic arthritis, which was on average 194 months (16 years) with a median of 174 months (14.5 years), ranging between 08 and 540 months (45). There was no difference between the groups regarding the type of psoriasis and the diagnosis of psoriatic arthritis, chart 2.
It was observed that none of the five patients with psoriasis guttata had a diagnosis of psoriatic arthritis; however, the two patients with nail psoriasis were classified as having psoriatic arthritis.
There was no significant association between lesions on the scalp, nail involvement and the diagnosis of psoriatic arthritis. The patients with arthritis were classified according to the type of involvement in oligoarthritis (three or 10% of patients), polyarthritis (20 or 67% of patients) and spondyloarthritis (seven or 23% of patients).
Patients with psoriatic arthritis had more enthesitis than the group without arthritis (Chart 3). There Fischer exact test, * p≤0,05 1 was no association between the presence of enthesitis and the type of psoriatic arthritis. However no patient with oligoarthritis had enthesitis. The diagnosis of dactylitis was found in 46.7% of those diagnosed with psoriatic arthritis and in only 12.6% of those without a diagnosis of psoriatic arthritis. There was a weak association between the presence of dactylitis and psoriatic arthritis. Table 1 presents the values of ESR and CRP in the groups.
The values of ESR and CRP were not different between the groups with and without psoriatic arthritis (Mann-Whitney test, p> 0.05). However there was a tendency to a higher value of CRP in the group with psoriatic arthritis.
In the group of patients with psoriatic arthritis nine patients (30%) used anti-inflammatory, twelve (40%) patients used disease-modifying drugs and seven (23.3%) patients used biological medications. Table 2 presents the final diagnosis of rheumatic manifestations. It is noteworthy that only 31% of the patients with psoriasis from the sample had no musculoskeletal manifestation.
DISCUSSION
It has been difficult to estimate the prevalence of psoriatic arthritis as the results of epidemiological studies have been influenced by several factors: the diagnostic criteria used, the frequency of psoriasis in different geographical areas, the average population age, the case definition and the methodology of the study. 9 Overall, in studies assessing the prevalence of psoriatic arthritis in patients with psoriasis seen at specific clinics it can vary from 6-42%. 2 In studies involving outpatients such as the one by Altobelli et al. 13 the prevalence rates reached 26% and in studies with populations that included both individuals and the community hospital environment such as the study by Reich et al. 14 the prevalence reached 20, 6%. Cross-sectional studies with populations referred to hospital care tend to have a higher prevalence and this is partly explained by a more intense and systematic research to define a case and partly because this group tends to be in the more severe spectrum of the disease. Our study found a high prevalence of psoriatic arthritis (35%) when we considered the patients who were previously diagnosed and those who met the CASPAR criteria, at the moment of this study. Despite the selection bias, on the other hand, we were careful in trying to make our estimates closer to reality. The study patients had their diagnosis confirmed after clinical evaluation by a dermatologist and a rheumatologist and, as told by Ibrahim et al., such studies often have estimates closer to reality.
15
Despite the small sample size, statistical significance was achieved in important variables. When compared to the only Brazilian study that evaluates the prevalence of psoriatic arthritis in psoriasis patients our study had the largest number of patients assessed, in addition to being a cross-sectional study. The study of Aslanian et al. was done by retrospective analysis of medical records.
16
Most of our patients presented with psoriasis vulgar, most commonly associated with psoriatic arthritis, but no difference was seen between the groups regarding the type of psoriasis and the diagnosis of psoriatic arthritis. The time elapsed between the onset of symptoms and the diagnosis of psoriatic arthritis was 16 years, which shows that in our environment the diagnosis of arthritis is usually delayed.
2
According to a review article the majority of patients (70%) developed psoriasis before the joint involvement, which was also observed in our study. Because the disease tends to present initially in the skin, it is important that the dermatologist identifies the signs of arthritis and then refer the patients to a rheumatologist. We observed that after the evaluation by a rheumatologist, 17 new cases of psoriatic arthritis were detected. This was also demonstrated in the 17 We know that in our country the access to a rheumatologist is often difficult, but recent studies have shown that, fortunately, rheumatologists and dermatologists, when trained, can assess both the skin and the joints with a surprising degree of agreement and accuracy.
18 Thus, we conclude that the cooperation between these specialties for the early detection of psoriatic arthritis is very important.
19
Given the difficulty in making the diagnosis, some clinical features should be assessed to predict psoriatic arthritis. Although nail lesions occur more frequently in patients with psoriatic arthritis, this was not observed in our study. In other studies nail lesions were found in all patients with psoriatic arthritis. Despite our results, we consider that the presence of this type of injury suggests the need to investigate joint disease.
2 In the study by FLORANNE et al. scalp lesions were strongly associated with psoriatic arthritis. Despite the high frequency of patients with lesions in the scalp, there was no such correlation in our study. 20 More than 30% of the patients had no information in their protocols on these two variables and that may have influenced the results.
Dactylitis was associated with the presence of psoriatic arthritis, which was expected, since it is also part of the CASPAR criteria. 12 Although regarded as the primary lesion of psoriatic arthritis, enthesitis was not frequently found in our study and this may be because of the difficulty in the clinical evaluation, since most of the sites of enthesitis are deeply located and further evaluation by ultrasound or MRI is needed to define its presence.
9
High erythrocyte sedimentation rate and Creactive protein were present in 50% of cases but only the elevated C-reactive protein was correlated with a higher prevalence of psoriatic arthritis. This can be explained because the erythrocyte sedimentation rate is an indirect measure of inflammatory activity and can be influenced by a variety of factors including the age of the patient and the presence of large amounts of other proteins in the plasma. C-reactive protein is a better index of inflammatory activity.
21
Many studies have similar results to ours, where the polyarticular form is the most common, but we have to stress that the majority of our patients were not in the early stages of the disease, where the oligoarticular forms are more frequently found.
9
On the other hand, the Brazilian study by Bonfiglioli et al had different results: 62.7% had oligoarthritis, and spondyloarthritis was observed in 16.7% and polyarthritis in 15.7% of patients, ie, a much lower frequency of polyarthritis. 22 It should be noted, however, that this study was conducted in the outpatient population referred to rheumatology. This demonstrates that in Brazil more studies are needed to confirm and explain the reasons for these divergent distributions.
Some studies regard having a polyarticular disease as a factor of poor prognosis and this is the most commonly found pattern in our population.
23
The use of many medications early in the disease is also a factor of poor prognosis. Our patients with psoriatic arthritis, probably due to the fact that they had the polyarticular form, which carries the worst prognosis, and also because they had several comorbidities and illnesses such as diabetes, hypertension, and mechanical joint diseases, often had a high frequency of medication use.
CONCLUSION
Given the aggressive and debilitating potential of psoriatic arthritis, the need to draw a profile of the clinical, radiological and functional capacity of patients with psoriasis and psoriatic arthritis among us is increasingly important, since we know that results from epidemiological studies are variable and depend on a number of factors leading to limitations in their use and interpretation. In addition, cooperation between rheumatologists and dermatologists for the diagnosis and early institution of therapeutic strategies is important, thus avoiding many complications commonly associated with this disease. q (17, 3) 
